PRINTER'S NO.  1486

  

THE GENERAL ASSEMBLY OF PENNSYLVANIA

  

SENATE BILL

 

No.

1202

Session of

2011

  

  

INTRODUCED BY LEACH, ORIE, FONTANA, HUGHES, BREWSTER, FARNESE, COSTA, BROWNE, WASHINGTON, TARTAGLIONE AND BLAKE, JULY 25, 2011

  

  

REFERRED TO PUBLIC HEALTH AND WELFARE, JULY 25, 2011  

  

  

  

AN ACT

  

1

Amending the act of September 9, 1965 (P.L.497, No.251),

2

entitled, as amended, "An act requiring physicians, hospitals

3

and other institutions to administer or cause to be

4

administered tests for genetic diseases upon infants in

5

certain cases," providing for congenital heart defects

6

screening.

7

The General Assembly finds and declares as follows:

8

(1)  Congenital heart defects (CHDs) are structural

9

abnormalities of the heart that are present at birth. CHDs

10

range in severity from simple problems such as holes between

11

chambers of the heart, to severe malformations, such as

12

complete absence of one or more chambers or valves. Some

13

critical CHDs can cause severe and life-threatening symptoms

14

which require intervention within the first days of life.

15

(2)  According to the United States Secretary of Health

16

and Human Services' Advisory Committee on Heritable Disorders

17

in Newborns and Children, congenital heart disease affects

18

approximately seven to nine of very 1,000 live births in the

19

United States and Europe. The Federal Centers for Disease

 


1

Control and Prevention states that CHD is the leading cause

2

of infant death due to birth defect.

3

(3)  Current methods for detecting CHDs generally include

4

prenatal ultrasound screening and repeated clinical

5

examinations. While prenatal ultrasound screenings can detect

6

some major congenital heart defects, these screenings, alone,

7

identify less than half of all CHD cases, and critical CHD

8

cases are often missed during routine clinical exams

9

performed prior to a newborn's discharge from a birthing

10

facility.

11

(4)  Pulse oximetry is a noninvasive test that estimates

12

the percentage of hemoglobin in blood that is saturated with

13

oxygen. When performed on a newborn a minimum of 24 hours

14

after birth, pulse oximetry screening is often more effective

15

at detecting critical, life-threatening CHDs which otherwise

16

go undetected by current screening methods. Newborns with

17

abnormal pulse oximetry results require immediate

18

confirmatory testing and intervention.

19

(5)  Many newborn lives could potentially be saved by

20

earlier detection and treatment of CHDs if birthing

21

facilities in this Commonwealth were required to perform this

22

simple, noninvasive newborn screening in conjunction with

23

current CH screening methods.

24

This section shall be known and may be cited as the James

25

Matthew Mannix section.

26

The General Assembly of the Commonwealth of Pennsylvania

27

hereby enacts as follows:

28

Section 1.  The act of September 9, 1965 (P.L.497, No.251),

29

known as the Newborn Child Testing Act, is amended by adding a

30

section to read:

- 2 -

 


1

Section 4.1.  Congenital Heart Defects (CHDs) Screening.--The

2

department shall require each health care provider that provides

3

birthing and newborn care services to perform a pulse oximetry

4

screening a minimum of 24 hours after birth on every newborn

5

child in its care.

6

Section 2.  This act shall take effect in 90 days.

- 3 -